BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Inagaki C, Maeda D, Kimura A, Otsuru T, Iwagami Y, Nishida N, Sakai D, Shitotsuki R, Yachida S, Doki Y, Satoh T. Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report. World J Gastrointest Oncol 2019; 11(9): 761-767 [PMID: 31558980 DOI: 10.4251/wjgo.v11.i9.761]
URL: https://www.wjgnet.com/1948-5204/full/v11/i9/761.htm
Number Citing Articles
1
Amol Patel, Arti Sarin, Raghunath Marimuthu, Charan Sai Madarapu, A.G. Pandit, Divya Shelly, J. Sharanya, Vidya Veldore, P. Suresh, T.V.S.V.G.K. Tilak. Heterogeneous ERBB gene pathways, their targeted treatment and possible molecular mechanisms of resistance in metastatic gallbladder cancerMedical Journal Armed Forces India 2024;  doi: 10.1016/j.mjafi.2024.01.006
2
Capecitabine/lapatinibReactions Weekly 2019; 1781(1): 96 doi: 10.1007/s40278-019-71919-3
3
Nilam Bhasker, Faraz Ahmad. Gallbladder Cancer2023; : 269 doi: 10.1007/978-981-19-6442-8_15
4
Michael May, Alexander G. Raufi, Sina Sadeghi, Karen Chen, Alina Iuga, Yu Sun, Firas Ahmed, Susan Bates, Gulam A. Manji. Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the LiteratureThe Oncologist 2021; 26(8): 640 doi: 10.1002/onco.13800
5
Yanjun Sun, Junfeng Gong, Zhuang Li, Lin Han, Dengqun Sun. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapyPostgraduate Medicine 2024; : 1 doi: 10.1080/00325481.2024.2345585
6
Sameer Gupta, Puneet Prakash, Vijay Kumar, Arun Chaturvedi, Shashwat Tiwari. Gallbladder Cancer2023; : 249 doi: 10.1007/978-981-19-6442-8_14
7
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu. Overview of current targeted therapy in gallbladder cancerSignal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00324-2